SureTrader SureTrader
Home > Boards > US Listed > Biotechs > NorthWest Biotherapeutics (NWBO)

Vaccine To Cure Cancer: New Breakthrough In Cancer

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
john1045 Member Profile
 
Followed By 31
Posts 2,211
Boards Moderated 0
Alias Born 06/09/11
160x600 placeholder
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 9/23/2016 5:21:50 PM
NW Bio Presents Updated Data From DCVax®-Direct Phase I Trial At 5th Annual SMi Cancer Vaccines Conference in London "PR Newswire (US)" - 9/21/2016 1:52:00 PM
Friendable Inc. (OTC Pink: FDBL), Sony Corp’s (NYSE: SNE) Epic Records - Meghan Trainor Concert Ticket Giveaway a Success! "InvestorsHub NewsWire" - 9/20/2016 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/19/2016 2:48:13 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/19/2016 2:45:38 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 9/19/2016 6:02:53 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/15/2016 9:13:25 AM
Thinspace Technology, Inc. (OTC Pink: THNS) Announces New Family of Mobile Clients – 400% Growth Potential for 2017 "InvestorsHub NewsWire" - 9/15/2016 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/12/2016 12:20:02 PM
Traders News- What Are These Companies Prospects After Crossing Key Milestones? "InvestorsHub NewsWire" - 9/12/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/9/2016 9:04:08 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/6/2016 9:18:53 AM
NASDAQ Accepts NW Bio Remediation Plan For Shares and Warrants Previously Issued to Cognate BioServices "PR Newswire (US)" - 9/6/2016 8:55:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/26/2016 10:37:47 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/26/2016 10:35:40 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/26/2016 10:33:23 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/23/2016 9:28:24 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/9/2016 5:13:00 PM
Amended Statement of Beneficial Ownership (sc 13d/a) "Edgar (US Regulatory)" - 7/28/2016 4:40:53 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/11/2016 5:26:56 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 7/5/2016 5:19:22 PM
NW BIO ANNOUNCES A REGISTERED DIRECT OFFERING OF $3.7 MILLION WITH NEW INSTITUTIONAL INVESTORS "PR Newswire (US)" - 7/5/2016 9:00:00 AM
NW Bio Enters First 180-Day Grace Period Relating To Non-Compliance With Nasdaq $1.00 Per Share Bid Requirement "PR Newswire (US)" - 6/30/2016 5:25:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/30/2016 5:22:29 PM
Pre-Market Review on Biotechnology Equities -- Northwest Biotherapeutics, Titan Pharma, Ultragenyx Pharma, and Athersys "PR Newswire (US)" - 6/29/2016 8:30:00 AM
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist